Proton Pump Inhibitors in the Era of Immunotherapy: A Risk Worth Taking?

Sandra M. Herrmann

doi:10.6004/jnccn.2025.7121

Proton Pump Inhibitors in the Era of Immunotherapy: A Risk Worth Taking?

Sandra M. Herrmann

Nephrology and Hypertension

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	494-495
Number of pages	2
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	23
Issue number	11
DOIs	https://doi.org/10.6004/jnccn.2025.7121
State	Published - Nov 2025

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2025.7121

Cite this

@article{7476a101d48b4d258f43a7d0864e5120,

title = "Proton Pump Inhibitors in the Era of Immunotherapy: A Risk Worth Taking?",

author = "Herrmann, \{Sandra M.\}",

year = "2025",

month = nov,

doi = "10.6004/jnccn.2025.7121",

language = "English (US)",

volume = "23",

pages = "494--495",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "11",

}

TY - JOUR

T1 - Proton Pump Inhibitors in the Era of Immunotherapy

T2 - A Risk Worth Taking?

AU - Herrmann, Sandra M.

PY - 2025/11

Y1 - 2025/11

UR - https://www.scopus.com/pages/publications/105021290122

UR - https://www.scopus.com/pages/publications/105021290122#tab=citedBy

U2 - 10.6004/jnccn.2025.7121

DO - 10.6004/jnccn.2025.7121

M3 - Comment/debate

C2 - 41213268

AN - SCOPUS:105021290122

SN - 1540-1405

VL - 23

SP - 494

EP - 495

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 11

ER -

Proton Pump Inhibitors in the Era of Immunotherapy: A Risk Worth Taking?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this